Venetoclax in Relapsed or Refractory Multiple Myeloma

]]>(MedPage Today) -- At the recent 2019 American Society of Hematology annual meeting, researchers reported results of a comparison of venetoclax and placebo in combination with bortezomib and dexamethasone in patients with relapsed/refractory multiple...